Sofinnova Investments, Inc. Intercept Pharmaceuticals, Inc. Call Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $1.12 Million - $1.96 Million	-100,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $673,848 - $896,616	-50,400 Reduced 33.51%	100,000 $1.63 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $2.15 Million - $2.94 Million	150,400 New	150,400 $2.45 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.